Limitations and Potentials of In Vitro Sensitivity Testing of Human Small Cell Carcinoma of the Lung
The clonogenic assay has been proposed both as a tool for individually guided chemotherapy and as a preclinical drug evaluation system. Because tumor cells are heterogeneous it is unlikely that a test where only a minor fraction of the cells is tested can predict the sensitivity of all tumor cells in the patient. The pronounced negative accuracy reported can be explained on the basis of the patient populations being studied. The technical limitations of the test are presented, and it is concluded that with the present status of the test, it is only suited as a preclinical test system.
It is suggested that in vitro sensitivity testing of drugs in a panel of cell lines established from patients with small cell carcinoma of the lung might help to identify drugs that could alter the clinical course of the disease.
KeywordsAgar Agarose Titration Oncol Polypeptide
Unable to display preview. Download preview PDF.
- 10.Vindeløv L, Hansen HH, Spang-Thomsen M: Growth characteristics and heterogeneity of small cell carcinoma of the lung. In: Recent results in Cancer Research, Seeber, S (ed.), 97, pp 47–54. Springer-Verlag, Berlin, Heidelberg, 1985.Google Scholar
- 12.Anonymous: Clonogenic assays for the chemotherapeutic sensitivity of human tumours. Lancet, i: 780–781, 1982.Google Scholar
- 16.Umbach G, Spitzer G, Drewinko B: ‘Clumpogenic’ v clonogenic assay. Lancet ii: 628, 1983.Google Scholar
- 19.Rasey JS, Nelson NJ: Response of an in vivo-in vitro tumour to X-rays and cytotoxic drugs: effect of tumour disaggregation method on cell survival. Br J Cancer 41/suppl 4:217–221, 1980.Google Scholar
- 25.Van Putten LM, Lelieveld P: The effects of cytostatic drugs and radiotherapy on the cell cycle. In: Scientific foundations of oncology, Symington T, Carter RL (eds.). William Heinemann Medical Books Ltd, London, pp 136–145, 1976.Google Scholar
- 31.Engelholm SAa, Spang-Thomsen M, Brünner N, Nøhr I, Roed H, Vindeløv L: In vitro culturing of tumor cells on soft agar. In: Human tumor cloning, Salmon SE, Trent JM (eds.), Grune & Stratton, New York, pp 197–203, 1984.Google Scholar
- 38.Meyskens FL, Thomson SP, Moon TE: Quantitation of the number of cells within tumor colonies in semisolid medium and their growth as oblate spheroids. Cancer Res 44:271–277,Google Scholar
- 39.Kressner BE, Morton RRA, Martens AE, Salmon SE, Von Hoff DD, Soehnlen B: Use of an image analysis system to count colonies in stem cell assays of human tumors. In: Cloning of human tumor stem cells. Salmon SE (ed.), Alan R Liss, New York, pp 179–193, 1980.Google Scholar
- 47.Roed H, Vindeløv LL, Christensen IJ, Hansen HH, Spang-Thomsen M: Comparison of the potential of the 2 epipodophyllotoxin derivatives VP-16 and VM-26 on small cell cancer of the lung cell lines. Proc Am Assoc Cancer Res 26:1315, 1985.Google Scholar
- 52.Anonymous: Testing anti-cancer drugs. Lancet 1972, i:827–828, 1972.Google Scholar